Scientists probe gut to see how drugs really dissolve
NCT ID NCT05159427
First seen Jun 24, 2026 · Last updated Jul 21, 2026 · Updated 3 times
Summary
This study aims to understand how a modified-release diabetes drug called glipizide dissolves in the stomach and small intestine. Researchers will directly sample gut contents, blood, urine, and stool from 40 healthy volunteers after they take the drug. The goal is to improve lab models that predict drug dissolution, not to treat any condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Glipizide (a diabetes drug) in extended-release tablets and a stable isotope form
- What this could lead to
- If successful, this could help create better lab tests that predict how drugs dissolve in the human gut, improving future drug development.
- What could go wrong
- This is a very early, small study in healthy people, not patients. It focuses on measuring drug behavior, not treating any disease, so direct benefits are unlikely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN GASTROINTESTINAL PHYSIOLOGY DATA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States